Uniplan Investment Counsel’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Sell |
130,425
-12,376
| -9% | -$366K | 0.39% | 62 |
|
|
2025
Q1 | $4.26M | Buy |
142,801
+797
| +0.6% | +$23.8K | 0.41% | 61 |
|
|
2024
Q4 | $4.07M | Sell |
142,004
-1,880
| -1% | -$53.9K | 0.38% | 69 |
|
|
2024
Q3 | $5.56M | Sell |
143,884
-2,491
| -2% | -$96.3K | 0.49% | 51 |
|
|
2024
Q2 | $4.71M | Sell |
146,375
-543
| -0.4% | -$17.5K | 0.43% | 57 |
|
|
2024
Q1 | $5.7M | Sell |
146,918
-175
| -0.1% | -$6.79K | 0.45% | 53 |
|
|
2023
Q4 | $4.53M | Buy |
147,093
+44,477
| +43% | +$1.37M | 0.34% | 63 |
|
|
2023
Q3 | $2.32M | Buy |
+102,616
| New | +$2.32M | 0.18% | 98 |
|